Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SANJAY PATEL

Allopathic & Osteopathic Physicians Allergy & Immunology Allergy

NPI
1962445528
CMS profile
270137
Location
HIGHLAND, IN

General Payments · PY2018–2024

$7,075.86

  • Reported across 413 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,031.40

53 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,031.40 53

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $416.94 21
Genentech USA, Inc. $187.26 8
NOVARTIS PHARMACEUTICALS CORPORATION $178.38 10
CSL Behring $74.01 4
GlaxoSmithKline, LLC. $50.10 3
GENZYME CORPORATION $27.88 1
Amgen Inc. $19.71 1
ITI, Inc. $18.35 1
ALK-Abello, Inc $16.33 1
Kaleo, Inc. $15.37 1
Hikma Pharmaceuticals USA $13.56 1
OptiNose US, Inc. $13.51 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,436.99 92
PY2019 $1,202.34 83
PY2020 $675.14 40
PY2021 $838.87 54
PY2022 $1,190.80 57
PY2023 $700.32 34
PY2024 $1,031.40 53

Payment records · PY2024 (53)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ALK-Abello, Inc $16.33 07/18/2024 Food and Beverage Undisputed 01/23/2026 1099894043 CMS
Amgen Inc. $19.71 11/05/2024 Food and Beverage Undisputed 01/23/2026 1116001838 CMS
AstraZeneca Pharmaceuticals LP $13.45 01/11/2024 Food and Beverage Undisputed 01/23/2026 1104593392 CMS
AstraZeneca Pharmaceuticals LP $13.94 01/31/2024 Food and Beverage Undisputed 01/23/2026 1104581480 CMS
AstraZeneca Pharmaceuticals LP $83.68 02/01/2024 Food and Beverage Undisputed 01/23/2026 1104775726 CMS
AstraZeneca Pharmaceuticals LP $19.23 02/08/2024 Food and Beverage Undisputed 01/23/2026 1105375633 CMS
AstraZeneca Pharmaceuticals LP $19.22 02/28/2024 Food and Beverage Undisputed 01/23/2026 1105551172 CMS
AstraZeneca Pharmaceuticals LP $17.61 03/07/2024 Food and Beverage Undisputed 01/23/2026 1104763946 CMS
AstraZeneca Pharmaceuticals LP $16.53 03/21/2024 Food and Beverage Undisputed 01/23/2026 1105864760 CMS
AstraZeneca Pharmaceuticals LP $13.52 04/25/2024 Food and Beverage Undisputed 01/23/2026 1104438169 CMS
AstraZeneca Pharmaceuticals LP $21.91 05/16/2024 Food and Beverage Undisputed 01/23/2026 1105858060 CMS
AstraZeneca Pharmaceuticals LP $14.36 06/27/2024 Food and Beverage Undisputed 01/23/2026 1105791584 CMS
AstraZeneca Pharmaceuticals LP $15.17 07/10/2024 Food and Beverage Undisputed 01/23/2026 1105746969 CMS
AstraZeneca Pharmaceuticals LP $17.79 08/08/2024 Food and Beverage Undisputed 01/23/2026 1104657663 CMS
AstraZeneca Pharmaceuticals LP $13.80 08/29/2024 Food and Beverage Undisputed 01/23/2026 1104693620 CMS
AstraZeneca Pharmaceuticals LP $19.74 09/03/2024 Food and Beverage Undisputed 01/23/2026 1104713747 CMS
AstraZeneca Pharmaceuticals LP $17.06 09/10/2024 Food and Beverage Undisputed 01/23/2026 1104593042 CMS
AstraZeneca Pharmaceuticals LP $14.35 09/24/2024 Food and Beverage Undisputed 01/23/2026 1105635462 CMS
AstraZeneca Pharmaceuticals LP $16.28 10/29/2024 Food and Beverage Undisputed 01/23/2026 1104504910 CMS
AstraZeneca Pharmaceuticals LP $15.01 11/20/2024 Food and Beverage Undisputed 01/23/2026 1105698520 CMS
AstraZeneca Pharmaceuticals LP $22.63 11/21/2024 Food and Beverage Undisputed 01/23/2026 1104752286 CMS
AstraZeneca Pharmaceuticals LP $18.43 12/12/2024 Food and Beverage Undisputed 01/23/2026 1104363417 CMS
AstraZeneca Pharmaceuticals LP $13.23 12/17/2024 Food and Beverage Undisputed 01/23/2026 1105661420 CMS
CSL Behring $24.59 01/23/2024 Food and Beverage Undisputed 01/23/2026 1134604561 CMS
CSL Behring $16.88 04/24/2024 Food and Beverage Undisputed 01/23/2026 1134604587 CMS
CSL Behring $17.71 05/21/2024 Food and Beverage Undisputed 01/23/2026 1134604597 CMS
CSL Behring $14.83 10/03/2024 Food and Beverage Undisputed 01/23/2026 1134604621 CMS
Genentech USA, Inc. $26.34 03/05/2024 Food and Beverage Undisputed 01/23/2026 1133106837 CMS
Genentech USA, Inc. $16.82 05/14/2024 Food and Beverage Undisputed 01/23/2026 1133106830 CMS
Genentech USA, Inc. $23.93 06/12/2024 Food and Beverage Undisputed 01/23/2026 1133106833 CMS
Genentech USA, Inc. $21.55 07/16/2024 Food and Beverage Undisputed 01/23/2026 1133106842 CMS
Genentech USA, Inc. $30.14 08/13/2024 Food and Beverage Undisputed 01/23/2026 1133106846 CMS
Genentech USA, Inc. $32.67 10/15/2024 Food and Beverage Undisputed 01/23/2026 1133106849 CMS
Genentech USA, Inc. $14.81 11/12/2024 Food and Beverage Undisputed 01/23/2026 1133106854 CMS
Genentech USA, Inc. $21.00 12/05/2024 Food and Beverage Undisputed 01/23/2026 1133106858 CMS
GENZYME CORPORATION $27.88 06/04/2024 Food and Beverage Undisputed 01/23/2026 1139683945 CMS
GlaxoSmithKline, LLC. $15.38 03/12/2024 Food and Beverage Undisputed 01/23/2026 1116241371 CMS
GlaxoSmithKline, LLC. $19.84 06/17/2024 Food and Beverage Undisputed 01/23/2026 1116009622 CMS
GlaxoSmithKline, LLC. $14.88 10/22/2024 Food and Beverage Undisputed 01/23/2026 1115915219 CMS
Hikma Pharmaceuticals USA $13.56 02/27/2024 Food and Beverage Undisputed 01/23/2026 1127505570 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.35 10/22/2024 Food and Beverage Undisputed 01/23/2026 1143293722 CMS
kaleo, Inc. $15.37 07/30/2024 Food and Beverage Undisputed 01/23/2026 1126629918 CMS
Novartis Pharmaceuticals Corporation $13.99 01/09/2024 Food and Beverage Undisputed 01/23/2026 1087218951 CMS
Novartis Pharmaceuticals Corporation $13.87 02/20/2024 Food and Beverage Undisputed 01/23/2026 1087218947 CMS
Novartis Pharmaceuticals Corporation $22.01 03/14/2024 Food and Beverage Undisputed 01/23/2026 1087218949 CMS
Novartis Pharmaceuticals Corporation $21.42 04/16/2024 Food and Beverage Undisputed 01/23/2026 1087218959 CMS
Novartis Pharmaceuticals Corporation $15.40 06/25/2024 Food and Beverage Undisputed 01/23/2026 1087218969 CMS
Novartis Pharmaceuticals Corporation $1.14 06/25/2024 Food and Beverage Undisputed 01/23/2026 1087218971 CMS
Novartis Pharmaceuticals Corporation $29.77 07/23/2024 Food and Beverage Undisputed 01/23/2026 1087218973 CMS
Novartis Pharmaceuticals Corporation $19.42 09/05/2024 Food and Beverage Undisputed 01/23/2026 1087218979 CMS
Novartis Pharmaceuticals Corporation $19.77 10/07/2024 Food and Beverage Undisputed 01/23/2026 1087218983 CMS
Novartis Pharmaceuticals Corporation $21.59 11/06/2024 Food and Beverage Undisputed 01/23/2026 1087218985 CMS
Optinose US, Inc. $13.51 06/13/2024 Food and Beverage Undisputed 01/23/2026 1142188286 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.